Pfizer board to consider audited financial results & dividend

26 Apr 2018 Evaluate

Pfizer has informed that a meeting of the Board of Directors of the Company is scheduled to be held on May 07, 2018, to consider and take on record the Audited Financial Results of the Company for the financial year ended March 31, 2018. At the said meeting, the Board of Directors will also consider recommendation of dividend, if any, for the financial year ended March 31, 2018. Further, the Trading Window for trading in the Equity shares of the Company will be closed from April 27, 2018 to May 09, 2018.

The above information is a part of company’s filings submitted to BSE.

Pfizer Share Price

4595.60 -127.70 (-2.70%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×